LifeTech Scientific Corporation
LFTSFOTCHealthcare● Active
$0.20
$-0.04(-16.49%)
Market Cap$858149643
P/E Ratio—
52W High$0.2335
52W Low$0.195
LifeTech Scientific Corporation (LFTSF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · LFTSF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.30B | $1.27B | $1.10B | $0.93B | $0.64B |
| Cost of Revenue | $0.32B | $0.27B | $0.22B | $0.18B | $0.13B |
| Gross Profit | $0.98B | $1.00B | $0.87B | $0.75B | $0.51B |
| Gross Margin %(computed) | 75.28% | 78.57% | 79.64% | 80.79% | 79.89% |
| Operating Expenses | |||||
| R&D Expenses | $0.30B | $0.30B | $0.21B | $0.15B | $0.17B |
| G&A Expenses | $0.16B | $0.15B | $0.10B | $0.10B | $0.10B |
| Total Operating Expenses | $0.80B | $0.61B | $0.50B | $0.42B | $0.25B |
| Operating Income | $0.19B | $0.38B | $0.38B | $0.33B | $0.26B |
| Operating Margin %(computed) | 14.29% | 30.25% | 34.26% | 35.53% | 41.18% |
| Interest Income | $0.02B | $0.01B | $0.02B | $0.01B | $0.01B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.03B |
| Income Before Tax | $0.20B | $0.18B | $0.38B | $0.33B | $0.24B |
| Income Tax Expense | $0.03B | $0.07B | $0.06B | $0.05B | $0.04B |
| Net Income | $0.22B | $0.26B | $0.33B | $0.29B | $0.22B |
| Net Margin %(computed) | 17.06% | 20.77% | 29.65% | 31.61% | 33.64% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.05 | $0.06 | $0.08 | $0.07 | $0.05 |
| Wtd Avg Shares | 4.38B | 4.46B | 4.23B | 4.56B | 4.34B |
| EBITDA | $0.29B | $0.25B | $0.45B | $0.40B | $0.31B |
| EBITDA Margin %(computed) | 22.16% | 20.00% | 40.63% | 42.97% | 48.91% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · CNY · B
Explore more LifeTech Scientific Corporation data
About LifeTech Scientific Corporation (LFTSF) Income Statement
LifeTech Scientific Corporation (LFTSF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2024, LFTSF reported revenue of $1.30B, gross profit of $0.98B (gross margin 75.28%), and net income of $0.22B — a net profit margin of 17.06%.
Frequently asked questions
LFTSF · 4 questionsLifeTech Scientific Corporation (LFTSF) reported revenue of $1.30B for 2024, up 2.9% year-over-year.
LFTSF revenueLFTSF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09